Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities    
Net income (loss) $ (4,247) $ 8,382
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 10,643 13,956
Amortization of deferred debt issuance costs 515 870
Stock compensation expense 2,491 2,342
Deferred income taxes (2,142) (462)
Release of reserve for uncertain tax positions, net 0 (2,343)
Loss on long-term cross currency swap 3,491 798
Remeasurement gain on intercompany balances (4,537) (147)
Changes in operating assets and liabilities:    
Accounts receivable 29,767 6,313
Inventories (9,431) (958)
Contract assets (3,169) 9,054
Other current and non-current assets (3,593) (4,432)
Accounts payable (17) 1,052
Accrued liabilities and non-current liabilities (1,228) (3,542)
Income taxes payable and receivable (5,939) (833)
Net cash provided by operating activities 12,604 30,050
Investing activities    
Purchases of property, plant and equipment (4,132) (3,839)
Sale of rental equipment 37 145
Net cash used in investing activities (4,095) (3,694)
Financing activities    
Proceeds from revolving credit facility 37,189 10,000
Payments on long-term debt and revolving credit facility (38,714) (23,131)
Purchase of shares from non-controlling interests 0 (4,508)
Proceeds from exercise of stock options 452 62
Repurchase of employee stock units on vesting (686) (879)
Payments on finance leases (139) (79)
Net used in financing activities (1,898) (18,535)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,304 (121)
Cash, cash equivalents and restricted cash at beginning of period 46,007 33,841
Cash, cash equivalents and restricted cash at end of period 53,922 41,541
Change in cash, cash equivalents and restricted cash $ 7,915 $ 7,700